# Early Detection of COVID-19 Using Breath Analysis

> **NCT04602884** · NA · COMPLETED · sponsor: **Scentech Medical Technologies Ltd** · enrollment: 50 (actual)

## Conditions studied

- Covid19

## Interventions

- **DIAGNOSTIC_TEST:** Breath biopsy sampling using the ReCIVA Breath Sampler

## Key facts

- **NCT ID:** NCT04602884
- **Lead sponsor:** Scentech Medical Technologies Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-22
- **Primary completion:** 2021-12-30
- **Final completion:** 2021-12-30
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2022-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04602884

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04602884, "Early Detection of COVID-19 Using Breath Analysis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04602884. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*